India to roll out DNA-based COVID shots for teens in October

120m adolescents await first-of-their-kind needle-free vaccine doses

20210901 Zydus Cadila India vaccine manufacturer

Zydus Cadila's vaccine was developed in India on a plasmid DNA platform that "can be easily adapted to deal with mutations," the company says. © Getty Images

KIRAN SHARMA, Nikkei staff writer

NEW DELHI -- India next month is expected to begin inoculating 12- to 18-year-olds with a domestically developed COVID-19 vaccine that is also the world's first DNA-based anti-coronavirus jab.

The vaccine has received approval for emergency use among this age group and older people.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.